Actualités

Discovery of a new genetic disease predisposing to mycobacterial infections

09/04/2021

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

09/04/2021

Institut Imagine accelerates research on autism spectrum disorders

25/03/2021

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

18/03/2021

Familial Hemophagocytic Lymphohystiocytosis and Digestive Malabsorption

17/03/2021

Research on nephronophthisis and renal ciliopathies at Imagine

16/03/2021

Towards a first treatment of severe ciliopathy in children

12/03/2021

Discover our web-conferences dedicated to rare diseases in replay

05/03/2021

Genetic deafness: an update on these pathologies, research and care

05/03/2021

Genetic deafness, which path of research and care for patients?

05/03/2021

Understanding genetic deafness

05/03/2021

Two type 1 interferopathies where the lung becomes inflamed

04/03/2021

6 new rare disease reference centers affiliated to the Institut Imagine

04/03/2021

From rare to frequent: the importance of conducting research on genetic diseases

23/02/2021

February 27 and 28, 2021: a weekend dedicated to rare diseases

15/02/2021